Published in
Springer (part of Springer Nature), Intensive Care Medicine, 6(48), p. 772-773, 2022
DOI: 10.1007/s00134-022-06669-2
Links
Tools
Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author’s reply
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 